Published October 19, 2023 | Originally published on MedicalXpress Breaking News-and-Events
Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and other diseases.
Aiming to encapsulate insulin-producing pancreatic cells and electronic sensors, the 3D-printed device was developed by a team from KTH Royal Institute of Technology and Karolinska Institutet. The researchers reported the results of the work in the journal Advanced Materials.
The collaboration between KTH and Karolinska Institutet enables micro-organs—namely pancreatic islets or islets of Langerhans—to be positioned precisely in the eye without the need for sutures. It offers the possibility of cell-based therapy, for example, to treat type 1 or type 2 diabetes, using the eye as a base…….
Source: MD Linx-This article was originally published on MedicalXpress Breaking News-and-Events.